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This randomized controlled trial of a cognitive/behavioral integrated intervention during 32 
pregnancy shows efficacy in reducing intimate partner violence victimization and 33 




OBJECTIVE:  We estimated the efficacy of a psycho-behavioral intervention in reducing 37 
intimate partner violence (IPV) recurrence during pregnancy and postpartum, and in improving 38 
birth outcomes in African-American women     39 
METHODS: We conducted a randomized controlled trial in which 1,044 women were recruited.  40 
Individually-tailored counseling sessions were adapted from evidence-based interventions for 41 
IPV and other risks. Logistic regression was used to model IPV victimization recurrence, to 42 
predict minor, severe, physical and sexual IPV. 43 
RESULTS:  Women randomized to the intervention were less likely to have recurrent episodes 44 
of IPV victimization (OR=0.48, 95%CI=0.29-0.80).  Women with minor IPV were significantly 45 
less likely to experience further episodes during pregnancy (OR=0.48, 95%CI=0.26-0.86, 46 
OR=0.53, 95%CI=0.28-0.99) and postpartum (OR=0.56, 95%CI=0.34-0.93). Numbers needed to 47 
treat were 17, 12, and 22, respectively as compared to the usual care Women with severe IPV 48 
showed significantly reduced episodes at postpartum (OR=0.39, 95%CI=0.18-0.82) and number 49 
needed to treat is 27. Women who experienced physical IPV showed significant reduction at the 50 
first follow-up (OR=0.49, 95%CI=0.27-0.91) and postpartum (OR=0.47, 95%CI=0.27-0.82) and 51 
number needed to treat is 18 and 20, respectively.  Intervention women had significantly fewer 52 
very preterm infants (p=0.03) and an increased mean gestational age (p=0.016). 53 
CONCLUSION: A relatively brief intervention during pregnancy had discernable effects on IPV 54 
and pregnancy outcomes.  Screening for IPV as well as other psychosocial and behavioral risks 55 
and incorporating similar interventions in prenatal care is strongly recommended. 56 
 57 





Intimate partner violence (IPV) is defined as a pattern of assaultive and coercive behaviors, that 62 
includes the threat or infliction of physical, sexual, or psychological abuse that is used by 63 
perpetrators for the purpose of intimidation of and/or control over the victim.1-3 There is no set 64 
agreement regarding what signs, symptoms or illnesses are considered the standard ICD-9 65 
constellation for a diagnosis of IPV.4,5   66 
The CDC reports that approximately 5.4 million episodes of IPV occur every year in the 67 
United States in women eighteen years and older. 6  The literature is inconsistent as to whether 68 
minorities are at increased risk, with some studies reporting significant differences7-10 and others 69 
finding no racial or ethnic differences.11,12   The most recent,  largest and nationally 70 
representative study found no differences of lifetime prevalence for IPV by race/ethnicity, while 71 
the rate for the 12 months preceding the survey was almost twice as high among African-72 
Americans.13  Although some authors link IPV to socio-economically deprived communities, it is 73 
by no means limited to the economically disadvantaged.  Families with conflicting priorities and 74 
stressors associated with limited psycho-social reserves may be at greatest risk.14  Factors 75 
including housing conditions, poverty and street violence are associated with higher prevalence 76 
of violence inside the home environment. Political disenfranchisement and cultural isolation may 77 
also be mediators for IPV. Women living under such conditions are more likely to be victimized 78 
as compared to women living in more stable and better organized communities.15-17  79 
Exposure to IPV is associated with a range of negative psycho-behavioral risks as well as 80 
health outcomes including increased risk of poor physical health, physical disability, 81 
psychological distress, mental illness, and heightened substance use including alcohol and illicit 82 
drugs.18 Sexual and physical IPV have been linked significantly with depression, suicidality, and 83 
post traumatic stress disorder.19-22   Women who suffer from IPV are more likely to have 84 
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sexually transmitted diseases, vaginal bleeding or infection and urinary tract infections.23 Abuse 85 
during pregnancy has been shown to be associated with significantly higher rates of depression, 86 
suicide attempts as well as use of tobacco, alcohol and illicit drugs.24-31 IPV has been linked to 87 
both pregnancy complications (e.g., inadequate weight gain, infections and bleeding) as well as 88 
adverse pregnancy outcomes (low birth weight (LBW), preterm delivery (PTB) and neonatal 89 
death).32-34 IPV amongst minority populations, already at higher risk for poor pregnancy 90 
outcomes, may be a significant contributor to the health disparities observed in reproductive 91 
outcomes amongst African-American women.   92 
The objective of this paper is to estimate the efficacy of a cognitive behavioral 93 
intervention administered as part of a randomized controlled trial (RCT) during prenatal care 94 
(PNC) in reducing IPV recurrence during pregnancy and improving birth outcomes (LBW and 95 
PTB) in a population of African-American residents of Washington, DC. 96 
PARTICIPANTS AND METHODS  97 
The “NIH-DC Initiative to Reduce Infant Mortality in Minority Populations” is a collaboration 98 
between Children’s National Medical Center, Georgetown University, George Washington 99 
University Medical Center, Howard University, the Eunice Kennedy Shriver National Institute of 100 
Child Health and Human Development, the National Center on Minority Health and Health 101 
Disparities and RTI International.  As part of this collaboration, we conducted a RCT to evaluate 102 
the efficacy of an integrated behavioral intervention delivered during PNC in reducing cigarette 103 
smoking, environmental tobacco smoke exposure (ETSE), depression and IPV during pregnancy 104 
and in improving pregnancy outcome.  This study was reviewed and approved by the 105 
institutional review boards of all participating institutions.   106 
Women were screened at six community based PNC sites serving mainly minority 107 
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women in the District of Columbia between July, 2001 and October, 2003.  Women were 108 
demographically eligible if they self-identified as being a minority, were >18 years old, <28 109 
weeks pregnant, a DC resident and English speaking. Almost two-thirds (63.4%) were recruited 110 
before 22 weeks gestation, 16.9% were recruited between 22 and 25 weeks gestation and 19.7% 111 
were recruited between 26 and 28 weeks gestation. The women who were demographically 112 
eligible were consented in a two-stage consent and enrollment process.  After initial consent, 113 
participants were screened for the four risk factors (cigarette smoking, ETSE, depression, and 114 
IPV) using an audio-computer assisted self interview which also confirmed their demographic 115 
eligibility.  An average of 9 days after screening, a baseline interview took place where more 116 
detailed information on socio-demographics, reproductive history and behavioral risks was 117 
collected.  Following this interview, women were consented to participate.    Follow-up data 118 
collection by telephone interviews occurred during the second and third trimesters of pregnancy 119 
(22-26 and 34-38 weeks gestation, respectively) and 8-10 weeks postpartum.  Intervention and 120 
follow-up activities continued until July 2004.  Details are published in El-Khorazaty et al.35 121 
A total of 2,913 women were screened and 1,398 met eligibility criteria (See Figure 1).  Of these 122 
85% (n=1,191) consented to participate in a baseline telephone interview before randomization; 123 
1,070 (89.9%) were reached and participated.  Eligible women were randomized to the 124 
intervention group or usual care group.  Of these women 1,044 were African-American and still 125 
pregnant at the time of the baseline interview.  Included in the analyses were 521 randomized to 126 
the intervention and 523 randomized to usual care.   127 
Women randomized to the intervention received an integrated cognitive behavioral 128 
intervention and women randomized to usual care received their usual prenatal care, as 129 
determined by the standard procedures at the PNC clinic.  336 women reported IPV 130 
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victimization in the past year during the baseline interview and this group could be further 131 
categorized as having minor and/or severe IPV, physical and/or sexual IPV based on the Conflict 132 
Tactics Scale (CTS).36 A woman may experience multiple types of violence; thus these 133 
categories are not mutually exclusive. Minor IPV was defined if the woman’s partner slapped, 134 
grabbed, pushed, or shoved her, threw something at her, twisted her arm or hair, and insisted, 135 
without using force, on anal sex, intercourse, or sex without using a condom.  Major IPV was 136 
defined if the woman’s partner kicked, bit, punched, beat up, hit, choked or slammed her, used 137 
knife or gun, burned or scalded her on purpose, and used force or threats to have sex or anal sex.  138 
Physical IPV was defined if the woman’s partner threw something at her, pushed or shoved her, 139 
used a knife or gun, hit, choked, slammed, grabbed, burned, or kicked her.  Sexual assault was 140 
defined if the woman’s partner forced sex without using a condom, forced her to have sex, 141 
threatened or insisted on having sex (oral, anal, or vaginal) against her will.   142 
The intervention utilized in this RCT was delivered during routine PNC visits at the 143 
clinics by interventionists (master’s level social workers or psychologists), trained specifically to 144 
deliver this intervention.  The intervention was evidence-based and specific to each of the 145 
designated psycho-behavioral risks.37  At each intervention session the woman identified which 146 
of the four risks she was experiencing.  The intervention was delivered by the interventionist and 147 
targeted to address all risks reported at each session, regardless of previously reported risks.  The 148 
intervention for IPV emphasized safety behaviors and was based on the structured intervention 149 
developed by Parker and colleagues38 and based on Dutton’s39 Empowerment Theory.  This 150 
intervention provided information about the types of abuse (e.g., emotional, physical and sexual) 151 
and the cycle of violence (e.g., escalating, IPV, honeymoon period), a Danger Assessment 152 
Component to assess risks, and preventive options women might consider (e.g., filing a 153 
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protection order) as well as the development of a safety plan (e.g., leaving important documents 154 
and papers with others).  In addition, a list of community resources with addresses and phone 155 
numbers was provided.  The intervention for smoking and ETSE were combined and based on 156 
Smoking Cessation or Reduction in Program Treatment.  This intervention was cognitive-157 
behavioral and based on a woman’s stage of readiness for behavioral change.40 The depression 158 
intervention was developed by Miranda and Munoz 41 based on cognitive behavioral theory and 159 
focused on mood management, increasing pleasurable activities and increasing positive social 160 
interactions.   161 
The components of the intervention were designed for delivery in a minimum of four 162 
sessions with eight prenatal sessions required for a complete intervention, based on the highest 163 
number of sessions required for a specific risk.  Fifty-one percent of the women randomized to 164 
the intervention received four or more sessions, while one-quarter of the women attended no 165 
intervention sessions. Individualized counseling sessions provided an integrated approach to 166 
multiple risks responsive to a woman’s specific risk combination.  Two additional postpartum 167 
booster sessions were provided to reinforce risk-specific intervention goals and support women 168 
through the postpartum period.  Intervention sessions were conducted privately in a room 169 
proximate to or within the PNC clinics and occurred immediately before or after routine PNC.  170 
Intervention activities addressing all of the individually identified risks at each session lasted for 171 
an average of 35+15 minutes.  Women in the intervention received $10 for each intervention 172 
session and additional $15 and $25 gift certificates for the first and second postpartum 173 
intervention sessions, respectively. 174 
During screening or follow-up, women reporting suicidal ideation were immediately 175 
referred to the mental health consultation team.  Women were evaluated and referred, as 176 
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necessary. Those found to be potentially suicidal (n=10) were excluded from the study.    177 
The sample size was powered to test the reduction in psycho-behavioral risk, with the 178 
theory that a reduction in risk would help improve pregnancy outcomes.  Assuming a 5% level of 179 
significance, 80% power would allow the detection of 10-20% reductions in risk-specific factors 180 
among women in the intervention from a prevalence of 100% at recruitment. A sample of 1,050 181 
women needed to be retained at the end of the follow-up period (525 women in each of the 182 
intervention and usual care group).  The anticipated number of women reporting IPV needed to 183 
detect significance in reducing risk was 337 split between the two care groups). This sample size 184 
was also sufficient to detect a 25% reduction in preterm birth and low birth weight combined in 185 
the intervention as compared to that for the usual care group (estimated at 20%). Based on a 186 
declining birth rate in D.C., the recruitment period was extended four months to reach the 187 
required sample size. 188 
Site- and risk-specific permuted block randomization to the intervention or usual care 189 
was conducted.  Both the investigators and the field workers were blinded to block size.  A 190 
computer generated randomization scheme was utilized to consider all the possible risk 191 
combinations within each of the recruitment sites.  When a woman completed the baseline 192 
interview and was ready for randomization, the recruitment staff would call the data coordinating 193 
center, where the subject’s assignment was determined. 194 
Validated instruments were used for each of the data collection time points.  During 195 
screening, IPV was identified by the Abuse Assessment Screen, a measure designed and 196 
validated for use in pregnancy if a woman reported physical or sexual abuse by a partner in the 197 
previous year.42 During the baseline and follow-up interviews, the frequency of physical assault 198 
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and sexual coercion (partner to self) was measured by the Conflict Tactics Scale.36 A more 199 
detailed description of instruments used for other risks is available in Katz et al.37   200 
Telephone interviewers and their supervisors were blinded to the participants’ 201 
randomization group.  Research staff maintained confidentiality when communicating with 202 
participants outside the clinic setting. Addresses were collected to facilitate tracing efforts, but 203 
the women were informed that they would not receive mail from Project DC-HOPE.  For women 204 
experiencing IPV, staff did not want to raise women’s risk for abuse by receiving mail from the 205 
study that might be negatively regarded by an abusive partner, or would expose her pregnancy.  206 
Women were also asked whether or not telephone messages from project staff could be left on 207 
their telephone answering machines. If not, this was noted in her computerized record accessible 208 
by all project teams. As financial incentives the women received $5 for the screening, a 30-209 
minute telephone card for providing main study consent, and $15 for each telephone interview. 210 
At the time of recruitment medical records were abstracted and upon delivery data on infant and 211 
pregnancy outcomes were recorded. 212 
To preserve the randomization, participant data were analyzed according to their care 213 
group assignment, regardless of receipt of intervention, using an intent-to-treat approach. All 214 
statistical analyses were conducting using SAS version 9.1.3 (SAS Institute, Cary, NC). 215 
Bivariate analyses were conducted to compare the baseline characteristics and pregnancy 216 
outcomes of women assigned to the intervention versus usual care and to compare women who 217 
reported a recurrence of IPV during pregnancy or postpartum versus those who did not. T-tests 218 
compared groups based on continuous variables (using the TTEST procedure in SAS) and chi-219 
square tests compared the groups with respect to categorical variables (using SAS’s FREQ 220 
procedure). Logistic regression was used to model recurrence of IPV based on care group 221 
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assignment, controlling for relevant covariates (using the LOGISTIC procedure). Logistic 222 
models were also created to predict minor, severe, physical and sexual IPV reported at each 223 
interview.  Adjusted odd ratios (AOR) were produced by models that included care group plus 224 
other covariates.  225 
RESULTS 226 
Table 1 presents the sociodemographic characteristics and psycho-behavioral risks at baseline 227 
between women randomized to the intervention (n=521) or usual care (n=523).  There were no 228 
significant differences between these two groups.  During the baseline interview, 336 women 229 
(32.2%) reported IPV in the previous year.  Of these women 169 were in the intervention and 230 
167 were in the usual care group (See Figure 1).  In this subgroup, there were no significant 231 
differences between the women in the two randomization groups (See Table 1).  Mothers were of 232 
24.5 years mean age.  On average participants initiated PNC at 13 weeks of gestation. Seventy-233 
six percent were single, 68% had at least a high school education and 79% were enrolled in 234 
Medicaid.  In this population, 22% of the mothers admitted to active smoking during pregnancy, 235 
78% self-identified as being at risk for ETSE and 62% were depressed as measured by the 236 
Hopkins Scale.  In addition, 32% admitted to using alcohol and 17% admitted to illicit drug use 237 
during pregnancy.   238 
Of those women reporting IPV at baseline, 306 women (91.1%) completed at least one of 239 
the follow-up or postpartum interviews.  No significant differences were found between those 240 
with follow-up data (n=306) and those without (n=30), nor were women randomized to the 241 
intervention (n=150) significantly different from those randomized to the usual care (n=156). 242 
Women reporting continued IPV during pregnancy or postpartum (n=94) were 243 
significantly different from those who reported no further episodes of IPV (n=212) beyond 244 
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baseline with respect to care group (p=0.006), gestational age at baseline (p=0.035), alcohol use 245 
during pregnancy (p=0.014) and depression at baseline (p=0.009). 246 
Controlling for these four variables in the logistic regression, only care group, alcohol use 247 
and depression were significant in the reduced model.  Logistic regression results for continued 248 
IPV at all interviews during pregnancy and postpartum (n=94) showed that women in the 249 
intervention were less likely to have recurrent episodes of IPV (AOR=0.48, 95% CI=0.29-0.80).  250 
Alcohol use during pregnancy measured at baseline and depression were associated with the 251 
chance of recurrent episodes of IPV (AOR=1.85, 95% CI=1.09-3.12; AOR=1.90, 95% CI=1.11-252 
3.25, respectively). Women in the intervention were less likely to be victimized by their partners 253 
at the first or second follow-up interviews (second or third trimester) (see Table 2). Although the 254 
trend remains, the difference does not reach significance in the postpartum period.  255 
Table 3 presents adjusted odds ratios and numbers needed to treat for the impact of the 256 
intervention on minor IPV, severe IPV, physical IPV and sexual IPV at baseline and each of the 257 
follow-up interviews.  It should be noted that reported IPV at baseline refers to the one year 258 
preceding the interview while at each of the three subsequent interviews, the reference period 259 
was since the previous interview, on average 9-10 weeks during pregnancy and 14 weeks 260 
between the second follow-up and the postpartum interview. At baseline no significant 261 
differences between groups were observed for any of these four categories.  Women with minor 262 
IPV and randomized to the intervention were significantly less likely to experience further 263 
episodes at all of the follow-up points.  Women categorized with severe IPV in the intervention, 264 
showed a significantly reduced incidence of episodes at postpartum, compared to the usual care 265 
group.  Women experiencing physical IPV were significantly less likely to experience episodes 266 
at first follow-up or at postpartum interviews, compared to the usual care group.  For women 267 
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experiencing sexual IPV, the intervention did not significantly reduce their incidence of episodes 268 
at any follow-up visit during pregnancy or postpartum.     269 
For women experiencing IPV victimization throughout pregnancy and postpartum, Table 270 
4 presents a comparison of intervention and usual care women with respect to various adverse 271 
pregnancy outcomes.  The results indicate that rates of low birthweight (<2,500 grams) (LBW) 272 
were not different in the two groups (intervention=12.8% versus usual care=18.5%, p=0.204), 273 
while very low birthweight (<1,500 grams) (VLBW) rates were lower among intervention 274 
women (intervention=0.8% versus usual care=4.6%, p=0.052).  In addition, rates of preterm 275 
births (37 weeks gestation) (PTB) were not statistically different in the two groups (13.0% versus 276 
19.7%, p=0.135).  However, the two groups of women were significantly different with respect 277 
to very PTB (<33 weeks gestation) (VPTB) (1.5% versus 6.6%, p=0.030).  Also, for the mean 278 
gestational age at delivery, the two groups were significantly different (38.2 weeks versus 36.9 279 
weeks, p=0.016). 280 
DISCUSSION 281 
This study evaluates efficacy of a psycho-behavioral intervention during prenatal and postpartum 282 
care on the reduction of IPV recurrence and improved pregnancy outcomes in African-American 283 
mothers reporting IPV victimization.  We were able to recruit 336 women acknowledging IPV 284 
victimization within the past year during the baseline interview and who were willing to 285 
participate in the intervention.  In addition, 91% of these women continued to participate in this 286 
randomized trial during pregnancy and/or postpartum.  This finding emphasizes the relative ease 287 
of recruitment of high risk African-American women to IPV reduction programs in the PNC 288 
setting.  The recruitment staff were trained to be culturally sensitive and the screening tool was 289 
both simple and administered confidentially.  These women are also willing to maintain 290 
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participation in a program that provided cognitive behavioral strategies relevant to psycho-291 
behavioral problems they experienced during pregnancy.   292 
The integrated intervention provided women with suggestions to deal with depression 293 
and tobacco exposure in addition to strategies aimed at reducing risk of IPV.  Alternative 294 
explanations for our findings were considered.  For other services for which we queried the 295 
women, there were no differences between women experiencing IPV and those not.  We also 296 
considered whether women’s previous reproductive history might explain why the intervention 297 
group had significantly better outcomes.  None of the factors (previous preterm delivery, 298 
previous miscarriage, previous stillbirth, number of previous voluntary interruptions of 299 
pregnancy) that might predict poor reproductive outcomes were different between the two care 300 
groups.  Finally we considered whether medical conditions that might influence pregnancy 301 
outcomes (preconception and gestational diabetes, chronic and gestational hypertension, or 302 
sexually transmitted infections) were significantly different between the two care groups. None 303 
of these medical conditions were significantly different between the two care groups. 304 
The American College of Obstetricians and Gynecologists identifies the response to 305 
domestic violence against women as a priority and recommends screening within primary care 306 
settings.43   They also recommend the Patient Health Questionnaire as a screening instrument for 307 
IPV, depression and anxiety.  This questionnaire recognizes the co-occurrence of these psycho-308 
social risks as well as screening for substance exposure known to occur more frequently in 309 
victims of IPV.24-27, 31   The findings of our study confirm the importance of emphasizing a more 310 
global approach towards risk assessment and service provision to this population of high risk 311 
African-American mothers.   312 
IPV has been associated with poor pregnancy outcomes in the literature.28, 30, 32-34, 44-47    313 
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Our study is the first we are aware of that found reductions in adverse pregnancy outcomes 314 
despite previous evidence for associations between IPV during pregnancy and LBW.28, 30, 32-34  315 
The intervention model targeting multiple risk factors in African-American women suffering 316 
from IPV victimization shows promising results that could be translated toward reduction of 317 
infant mortality within that population.  The current literature agrees that very preterm infants 318 
contribute more than 90% of the overall infant mortality statistic.48 The effect of the intervention 319 
impacted multiple pregnancy outcomes, especially the highest level of neonatal risk, VLBW and 320 
VPTB.  The significant reduction of VLBW and VPTB in our intervention group may have 321 
important implications on reduction of disparities in poor pregnancy outcomes and infant 322 
mortality among African-Americans.   323 
Whether or not our analyses were adjusted for alcohol use and depression, the 324 
intervention universally reduced minor IPV during pregnancy and postpartum.  It is important to 325 
recognize that the classification of minor IPV on the Conflict Tactics Scale includes acts of 326 
assault such as slapping, grabbing, pushing and shoving as well as twisting of the arm or hair. 327 
While such actions may be considered minor on the CTS they are significant acts of aggression 328 
and violence.  The intervention was unable to impact more severe acts described as using a knife 329 
or gun, choking, burning, scalding or kicking.  The lack of effect on sexual IPV could be 330 
attributed to the reluctance or discomfort of the study participants to divulge or discuss these 331 
topics.  The intervention team was instructed to show sensitivity to the level of comfort of the 332 
study participants in this domain.  The intervention as designed and implemented only reduced 333 
the recurrence of minor and physical IPV, but could have reduced other associated risks.   334 
The impact of IPV on pregnancy outcome is complicated by its co-occurrence with 335 
depression and alcohol use.47,49-51  The behavioral intervention for depression could have 336 
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significantly contributed to our success. Among the women reporting IPV at baseline, 62 percent 337 
reported being depressed and 32 percent reported alcohol use during pregnancy.  Addressing IPV 338 
and depression together may have helped women implement suggested strategies to assess risks, 339 
consider preventive options and develop a safety plan.   We also detected a significant 340 
association between IPV and illicit drug use (16.7%) and active smoking (22%), both known to 341 
be risks for PTB and LBW.52,53  In reduced logistical models, alcohol use during pregnancy and 342 
depression measured at baseline continued to exert a significant influence on perpetuating IPV 343 
during pregnancy and postpartum.  This describes a cycle where co-occurring risk factors are 344 
immutably entangled.   345 
A limitation of the study was that it was not powered to test the efficacy of the 346 
intervention with respect to adverse pregnancy outcomes, but rather resolution of the psycho-347 
behavioral risks.  Women were only modestly invested in participating in the intervention.  348 
Despite the fact that we were able to deliver the minimum number of intervention sessions to 349 
59% of participants with IPV, women randomized to the intervention were successful in risk 350 
reduction.  These rates of participation may be a reflection of difficult life circumstances among 351 
poor urban women. These mothers encountered other behavioral challenges during pregnancy, 352 
such as alcohol and drug use, that were not addressed by the intervention.  Had we addressed 353 
these, we might have been even more successful. The intervention effect(s) we found may apply 354 
only to high risk minority pregnant women. It would be important to test this intervention in 355 
other racial or sociodemographic groups to confirm generalizability.  Larger studies testing the 356 
effectiveness of implementing such interventions in community based clinics providing PNC 357 
could have important health policy implications.  358 
There is evidence that this intervention for pregnant African-American women reduced 359 
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IPV victimization during pregnancy and improved pregnancy outcome.  If generalizable, our 360 
results should encourage health care providers and third party payers to go beyond screening for 361 
psycho-social and behavioral risks to providing services during PNC to address such risks.  The 362 
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Screened for Eligibility 
N = 2913 
   Ineligible: N = 1515* 
 
No Risk = 513 
<18 years old = 22 
>28 weeks EGA = 658 
Not race eligible = 331 
Not DC residents = 41 
Not pregnant = 25 
Participation Exclusion = 25 
Suicidal = 2 
Other Exclusion = 2 
 
• More than one reason for 
• ineligibility may apply. 
 
Eligible Women 
N = 1398 
   Consented & No 
Baseline Data: N = 121 
 
Refused Interview = 17 
Unable to Locate = 70 
No longer pregnant. = 24 
Other = 10 
Consented, Completed 
Baseline Interview 
& Randomized: N = 1070 
African-American 
N = 1044 
Non African-American: N = 22 
No Longer Pregnant: N = 4 
Data Available on IPV 
Episodes: N = 150 
IPV at Baseline 
N = 169 
No IPV at Baseline 
N = 352 
Figure 1.  Profile of Project DC-HOPE Randomized Controlled Trial 
No consent: N = 207 
Refused Consent = 165 
Consent not Signed = 42 
 
No Data Available on IPV 
Episodes: N = 19  
Intervention: N = 521 Usual Care: N = 523 
Data Available on IPV 
Episodes: N = 156 
IPV at Baseline 
N = 167 
No IPV at Baseline 
N = 356 
No Data Available on IPV 
Episodes: N = 11 
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Table 1. Characteristics of All Participants and those Acknowledging Intimate Partner Violence 
(IPV) Victimization at Baseline 
 










Maternal age Mean ± SD 24.4+5.5 24.8+5.3 24.5+5.8 24.5+5.4 




< High school 159 (30.5%) 157 (30.0%) 54 (32.0%) 53 (31.7%) 
HS graduate/GED 245 (47.0%) 241 (46.1%) 77(45.6%) 67 (40.1%) 








Working now 185 (35.5%) 196 (37.5%) 58 (34.3%) 67 (40.4%) 
Not working now, worked 
previous to pregnancy 
185 (35.5%) 193 (36.9%) 67 (39.6%) 59 (35.5%) 
Not working now, did not 
work previous to pregnancy 
150 (28.8%) 130 (24.9%) 44 (26.0%) 40 (24.1%) 
Relationship status Single/separated/widowed/
divorced 
396 (76.0%) 401 (76.7%) 132 (78.1%) 122 (73.1%) 
Married or living with 
partner 
125 (24.0%) 122 (23.3%) 37 (21.9%) 45 (27.0%) 
Emotional support from partner Mean ± SD 36.9+20.6 37.3+20.5 32.8+20.9 32.7+19.7 
Emotional support from others Mean ± SD 39.4+15.1 40.8+14.7 37.7+14.9 39.3+14.9 
Emotional support from partner prior 
to delivery 
Mean ± SD 34.3+21.6  33.9+21.8 31.0+21.9 29.6+21.6 
Emotional support from others prior to 
delivery 
Mean ± SD 41.8+12.7 41.7+13.4 40.5+13.7 39.9+14.7 
Trimester of PNC initiation 1st Trimester 305 (61.6%0 300 (58.9%) 94 (58.8%) 98 (60.9%) 
2nd Trimester 179 (36.2%) 201 (39.5%) 60 (37.5%) 60 (37.3%) 
3rd Trimester 11 (2.2%) 8 (1.6%) 6 (3.8%) 3 (1.9%) 
Medicaid Yes 411 (78.9%) 402 (76.8%) 134 (79.8%) 129 (77.7%) 
WIC Yes 226 (43.4%) 228 (43.6%) 74 (43.8%) 76 (45.5%) 
Supplemental food program Yes 369 (71.1%) 382 (73.0%) 168 (99.4%) 162 (97.0%) 
Public assistance/TANF Yes 213 (41.0%) 223 (42.7%) 73 (43.2%) 69 (41.3%) 
Alcohol use in this pregnancy Yes 111 (21.3%) 112 (21.4%) 58 (34.3%) 49 (29.3%) 
Illicit drug use in this pregnancy Yes 67 (12.9%) 56 (10.7%)  26 (15.4%) 30 (18.0%)  
Marijuana use Yes 62 (11.9%) 52 (9.9%) 23 (13.6%) 28 (16.8%) 
Cocaine use Yes 6 (1.2%) 7 (1.3%) 5 (3.0%) 3 (1.8%) 
Pregnancy 'wanted' Yes 403 (77.4%) 395 (75.5%) 127 (76.1%) 117 (71.3%) 
Previous pregnancy Yes 425 (81.6%) 443 (84.7%) 141 (83.4%) 144 (86.2%) 
Previous live birth Yes 173 (33.2%) 163 (31.2%) 112 (69.5%) 116 (69.5%) 
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Number of live births (women with 
previous pregnancy) 
Mean ± SD 2.1+1.5 2.2+1.4 1.9+1.7 1.7+1.5 
Previous preterm delivery Yes 72 (14.2%) 66 (12.7%) 30 (22.2%) 23 (16.4%) 
Previous stillbirth, miscarriage and 
loss (women with previous pregnancy) 
Yes 181 (42.6%) 192 (43.3%) 59 (42.1%)  68 (47.2%) 
Gestational diabetes Yes 25 (5.8%) 32 (7.0%) 8 (5.6%) 11 (7.5%) 
Preconception diabetes Yes 19 (3.7%) 18 (3.4%) 7 (4.2%) 4 (2.4%) 
Gestational hypertension Yes 14 (3.3%) 20 (4.4%) 3 (2.1%) 6 (4.1%) 
Chronic hypertension Yes 31 (6.0%) 29 (5.5%) 13 (7.8%) 5 (3.0%) 
Active smoking at baseline Yes 106 (20.3%) 92 (17.6%) 38 (22.5%) 36 (21.6%) 
ETSE at baseline Yes 365 (71.4%) 377 (73.3%) 128 (77.1%) 130 (78.8%) 
Depression at baseline Yes 229 (44.0%) 234 (44.7%) 101 (59.8%) 106 (63.5%) 
IPV at baseline Yes 169 (32.4%) 167 (31.9%) --- --- 
Active smoking prior to delivery Yes 70 (16.6%) 65 (15.2%) 24 (17.8%0 26 (19.6%) 
ETSE prior to delivery Yes 247 (58.7%) 277 (65.2%) 82 (61.2%) 89 (66.9%) 
Depression prior to delivery Yes 152 (35.9%) 170 (39.8%) 71 (52.6%) 71 (53.4%) 
Active smoking at postpartum Yes 89 (21.9%) 106 (25.0%) 31 (22..8%) 44 (31.9%) 
ETSE at postpartum Yes 196 (48.5%) 233 (55.9%) 63 ( 46.7%) 85 (63.0%) 
Depression at postpartum Yes 90 (22.2%) 118 (27.8%) 39 (28.9%) 51 (37.0%) 
Notes: (1) PNC: prenatal care; WIC: Supplemental Nutrition Program for Women, Infant and Children; TANF: Temporary                   
Assistance for Needy Families; ETSE: Environmental Tobacco Smoke Exposure; IPV: Intimate Partner Violence 
     (2) All characteristics are measured at baseline except when noted otherwise.  
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Table 2. Comparison of Intervention and Usual Care Groups by Continued IPV 
 
Characteristic Intervention Usual Care p-value 






















  Note: IPV: Intimate Partner Violence;  U1: First Follow-up (22-26 weeks gestation) interview;  
FU2: Second Follow-up (34-38 weeks gestation) interview; PP: Postpartum interview
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Table 3.  Adjusted Odds Ratios*  for the Impact of the Intervention on Various Categories of Intimate Partner Violence 
Victimization during Pregnancy and Postpartum 
 
 
Notes:  IPV: Intimate Partner Violence; BL: Baseline; FU1: First Follow-up (22-26 weeks gestation); FU2: Second Follow-up (34-38 weeks 
gestation); PP: Postpartum; AOR: Adjusted Odds Ratio; CI: Confidence Interval. 
* Adjusted for alcohol use during pregnancy and depression at baseline. 
** Absolute difference between intervention and usual care groups. 
*** Number needed to treat is calculated for significant adjusted odds ratios and significant risk differences. 
 
 
Intervention vs. Usual Care Minor IPV Severe IPV Physical IPV Sexual IPV 
BL:  
N (%) 
AOR (95% CI) 
Absolute Risk Difference** 
Number Needed to Treat (95% CI)*** 
 
 327 (31.4%) 




















AOR (95% CI) 
Absolute Risk Difference** 
Number Needed to Treat  (95% CI)*** 
 
56 (9.5%) 
0.48 (0.26 – 0.86) 
0.061 
17 (11 – 67) 
 
 24 (4.1%) 





0.49 (0.27 – 0.91) 
0.054 
18 (12 – 108) 
 
22 (3.7%) 





AOR (95% CI) 
Absolute Risk Difference** 
Number Needed to Treat  (95% CI)*** 
  
49 (6.8%) 
0.53 (0.28 – 0.99) 
0.083 
12 (5 – 642) 
  
16 (2.2%) 















AOR (95% CI) 
Absolute Risk Difference** 
Number Needed to Treat  (95% CI)*** 
  
72 (8.7%) 
0.56 (0.34 – 0.93) 
0.045 
22 (14 – 146) 
  
36 (4.4%) 
0.39 (0.18 – 0.82) 
0.037 
27 (20 – 96) 
  
62 (7.5%) 
0.47 (0.27 – 0.82) 
0.050 
20 (14 – 61) 
  
27 (3.3%) 




Table 4.  Pregnancy Outcomes among Women Experiencing Intimate Partner Violence 







LBW 17 (12.8%) 24 (18.5%) 0.204 
VLBW 1 (0.8%) 6 (4.6%) 0.052 
Birth Weight (grams): Mean + SD 3139 + 593 3098 + 717 0.618 
PTB 18 (13.0%) 27 (19.7%) 0.135 
VPTB 2 (1.5%) 9 (6.6%) 0.030 
Gestational Age at Delivery (weeks) : 
Mean + SD 
38.2 + 3.3 36.9 + 5.9 0.016 
Note: LBW: Low Birth Weight; VLBW: Very Low Birth Weight; PTB: Preterm Birth;  
VPTB: Very Preterm Birth; SD: Standard Deviation 
